{"ticker":"LGND","companyName":"LIGAND PHARMACEUTICALS INC","fiscalYear":2025,"executiveName":"Todd C. Davis","executiveTitle":"Chief Executive Officer","totalComp":11472095,"salary":724500,"stockAwards":5520493,"optionAwards":4441120,"nonEquityIncentive":764400,"otherComp":21582,"yoyChangePct":-11.172181451306933,"source":{"filingType":"DEF 14A","accession":"0000886163-26-000021","filingDate":"2026-04-21","filingUrl":"https://www.sec.gov/Archives/edgar/data/886163/000088616326000021/lngd-20260421.htm"},"lastUpdated":"2026-07-07T10:22:09.912Z","yoy_total_comp_pct":-11.172181451306933}